Sign up to save your podcasts
Or
Share Restoration of Immune Balance with Anish Suri, Ph.D., President and CSO at Cue Biopharma
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Restoration of Immune Balance with Anish Suri, Ph.D., President and CSO at Cue Biopharma
We love to hear from our listeners. Send us a message.
Cue Biopharma's Anish Suri, Ph.D., explains why the clinical-stage biopharma is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells directly within the body to transform the treatment of cancer.
Subscribe to the podcast!
Apple | Spotify | YouTube
Visit my website: Cell & Gene
Connect with me on LinkedIn
View all episodes
By Erin Harris
4.9
3838 ratings
We love to hear from our listeners. Send us a message.
Cue Biopharma's Anish Suri, Ph.D., explains why the clinical-stage biopharma is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells directly within the body to transform the treatment of cancer.
Subscribe to the podcast!
Apple | Spotify | YouTube
Visit my website: Cell & Gene
Connect with me on LinkedIn
More shows like Cell & Gene: The Podcast
View all
Freakonomics Radio
32,092 Listeners
Planet Money
30,687 Listeners
Motley Fool Money
3,222 Listeners
The Knowledge Project
2,670 Listeners
Nature Podcast
763 Listeners
HBR IdeaCast
181 Listeners
Immune
277 Listeners
The Readout Loud
324 Listeners
BioCentury This Week
34 Listeners
People I (Mostly) Admire
2,101 Listeners
Raising Health
146 Listeners
Biotech Hangout
19 Listeners
NEJM AI Grand Rounds
56 Listeners
ASGCT Podcast Network
16 Listeners
HBR On Leadership
165 Listeners